Skip to content

Research paper

Comparative analysis of the efficacies of probiotic supplementation and glucose-lowering drugs for the treatment of type 2 diabetes: A systematic review and meta-analysis

Frontiers in Nutrition
Q1
Jul 2022
Citations: 6
Influential: 1
Systematic Reviews / Meta-Analyses
87

Study answer

What this study found

Glucose-lowering drugs generally produced larger reductions in fasting blood glucose and HbA1c than probiotics, with GLP-1 receptor agonists and SGLT-2 inhibitors showing the strongest glycemic effects. Probiotic supplementation still showed beneficial metabolic effects, especially milder improvements in glycemic indices, insulin resistance, and lipid profiles. Probiotics were also associated with reductions in systolic and diastolic blood pressure, and some formulations lowered total cholesterol and triglycerides. Overall, probiotics may be more useful as an adjunct or for less severe type…

Study & population
Systematic review and meta-analysis of randomized studies in adults with type 2 diabetes from multiple countries.
Intervention
Oral probiotic supplementation was evaluated in multiple formulations, including capsules, sachets, synbiotic food, soy milk, kefir, and fermented milk products.
Key limitation
The included evidence had substantial heterogeneity, reflecting different probiotic strains, delivery forms, doses, and short treatment durations of about 6 to 12 weeks.
View sourceOpen PDF

Original abstract

The aim of this systematic review and meta-analysis was to evaluate the effects of probiotics and glucose-lowering drugs (thiazolidinedione [TZD], glucagon-like pep-tide-1 receptor agonists [GLP-1 RA], dipeptidyl peptidase IV inhibitors, and sodium g…